Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXS0CP
|
||||
Drug Name |
N-[7-Bromo-1-(3H-imidazol-4-ylmethyl)-4-methanesulfonyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-3-ylmethyl]-benzamide
|
||||
Synonyms |
CHEMBL119993
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C22H24BrN5O3S
|
||||
Canonical SMILES |
CS(=O)(=O)N1Cc2cc(Br)ccc2N(Cc3c[nH]cn3)CC1CNC(=O)c4ccccc4
|
||||
InChI |
InChI=1S/C22H24BrN5O3S/c1-32(30,31)28-12-17-9-18(23)7-8-21(17)27(13-19-10-24-15-26-19)14-20(28)11-25-22(29)16-5-3-2-4-6-16/h2-10,15,20H,11-14H2,1H3,(H,24,26)(H,25,29)
|
||||
InChIKey |
TYIREKPLERMDCV-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.